Except for the impact on proliferative vitality of tumor cells induced by KIF20A, the influence on in vitro chemosensitivity was also observed that KIF20A-silencing drastically increased sensitivity of tumor cells to cisplatin and sorafenib, while the intrinsic mechanism remained to be explored [84]. This evidence concerns the gene KIF20A and neoplasm.